- Home
- RHLD vs KOD Comparison
RHLD vs KOD Comparison
Compare RHLD & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RHLD
- KOD
- Stock Information
- Founded
- RHLD 2024
- KOD 2009
- Country
- RHLD United States
- KOD United States
- Employees
- RHLD N/A
- KOD N/A
- Industry
- RHLD
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RHLD
- KOD Health Care
- Exchange
- RHLD NYSE
- KOD Nasdaq
- Market Cap
- RHLD 217.1M
- KOD 198.4M
- IPO Year
- RHLD N/A
- KOD 2018
- Fundamental
- Price
- RHLD $37.22
- KOD $4.38
- Analyst Decision
- RHLD
- KOD Hold
- Analyst Count
- RHLD 0
- KOD 3
- Target Price
- RHLD N/A
- KOD $9.00
- AVG Volume (30 Days)
- RHLD 100.9K
- KOD 301.5K
- Earning Date
- RHLD 08-15-2025
- KOD 08-13-2025
- Dividend Yield
- RHLD N/A
- KOD N/A
- EPS Growth
- RHLD N/A
- KOD N/A
- EPS
- RHLD 12.54
- KOD N/A
- Revenue
- RHLD $420,450,000.00
- KOD N/A
- Revenue This Year
- RHLD N/A
- KOD N/A
- Revenue Next Year
- RHLD N/A
- KOD N/A
- P/E Ratio
- RHLD $3.18
- KOD N/A
- Revenue Growth
- RHLD 11.09
- KOD N/A
- 52 Week Low
- RHLD $24.22
- KOD $1.92
- 52 Week High
- RHLD $54.05
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- RHLD N/A
- KOD 65.72
- Support Level
- RHLD N/A
- KOD $3.70
- Resistance Level
- RHLD N/A
- KOD $4.01
- Average True Range (ATR)
- RHLD 0.00
- KOD 0.25
- MACD
- RHLD 0.00
- KOD 0.08
- Stochastic Oscillator
- RHLD 0.00
- KOD 97.70
About RHLD RESOLUTE HOLDINGS MANAGEMENT INC
Resolute Holdings Management Inc is provide operating management services. The company has two operating segments and two reportable segments: Payment Card and Arculus. Payment Card generates its revenue through the production and sale of metal payment cards while Arculus generates its revenue through the production and sale of metal payment or nonpayment cards containing Arculus technology for authentication and/or digital asset cold storage and related services. The company generates maximum revenue Domestically.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.